Showing 1761-1770 of 7447 results for "".
ISDPA: Dr. Lal on Therapeutic Updates
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-lal-therapeutic-updates/29149/Karan Lal, DO, discusses the latest therapeutic updates for atopic dermatitis and other conditions, including his strategies for utilizing dupilumab, at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.Chronic Hand Eczema Treatment Landscape
https://practicaldermatology.com/series/c-suite-chats/chronic-hand-eczema-treatment-landscape/29126/Jacob Thyssen, MD, PhD, Chief Scientific Officer at Leo Pharma, talks about the incidence of chronic hand eczema and the advantage that delgocitinib provides compared to other treatment options.Bring Pediatric Pearls Into Practice
https://practicaldermatology.com/conferences/maui-derm-2024/bring-pediatric-pearls-into-practice/20265/Resident Of Distinction Award-winner Maria Buethe, MD, PhD, a pediatric dermatology fellow at Rady Children’s Hospital in San Diego, talks about her favorite session at Maui Derm 2024 sharing technical and practice pearls for the treatment of dermatological conditions in children, including an interWhat Could Go Wrong with Fillers?
https://practicaldermatology.com/conferences/maui-derm-2024/what-could-go-wrong-with-fillers/20253/Joel L. Cohen, MD, explains the importance of understanding “what lies beneath” in order to more accurately evaluate post-procedure reactions and know how and when to intervene.What’s New With Neuromodulators?
https://practicaldermatology.com/conferences/maui-derm-2024/whats-new-with-neuromodulators/20252/Joel L. Cohen, MD, discusses the currently available neuromodulators as well as what’s on the radar, including ready-to-use liquid toxins and more.Why It’s Critical to Distinguish Between Rosacea Subtypes for Best Results
https://practicaldermatology.com/conferences/maui-derm-2024/why-its-critical-to-distinguish-between-rosacea-subtypes-for-best-results/20245/In the Acne and Rosacea Updates symposium, Hilary Baldwin, MD, explained how she evaluates and treats rosacea with phenotypic therapies based on which aspects of the disease patients are most concerned about.Scale 2023: Exclusive Preview from Music City
https://practicaldermatology.com/topics/practice-management/music-city-sound/20184/Michael Gold, MD, gives a sneak peek of the exciting agenda for the upcoming Music City SCALE 2023 meeting.Workplace Diversity: Spotting Opportunities and Overcoming Challenges
https://practicaldermatology.com/topics/practice-management/workplace-diversity-spotting-opportunities-and-overcoming-challenges/23762/An expert on workplace diversity and class bias shares insights to help all organizations improve.Why is CSF Different?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/why-is-csf-different/20124/Discover why CSF is different from other meetings. Attendees and faculty share their CSF experience and describe why they think the meeting and its new Nashville home make for “a great program.”Injectable Safety
https://practicaldermatology.com/conferences/maui-derm-2022/injectable-safety/20272/When using fillers in the face, it's important to think about the anatomy beneath the skin, says Joel L. Cohen, MD. He stresses the importance of going beyond text book and cartoon drawings of anatomy, which might not be complete, and thinking about cadaver studies to ensure a complete understanding